ArticleTherapeutic advances in hematology2025

Azacitidine followed by R-GDP in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: preliminary results from a multicenter, phase II study.

Dong Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.